| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $4.7B | $4.5B | $4.2B | $3.4B | $2.9B | $0.7B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | $0.2B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | $2.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.8B | $2.1B | $2.1B | $4.3B | $2.0B | $1.4B | $1.5B | $1.7B |
| EPS (Basic) | $9.04 | $10.68 | $11.11 | $23.64 | $9.91 | $6.29 | $1.88 | $3.05 |
| EPS (Diluted) | $9.01 | $10.64 | $11.06 | $23.50 | $9.87 | $6.29 | $1.87 | $3.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.2B | $19.8B | $19.8B | $17.6B | $17.4B | $11.8B | $11.4B | $10.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.4B | $0.4B | $0.8B | $0.7B | $0.3B | $0.4B | $0.4B |
| Total Liabilities | $10.9B | $9.9B | $9.7B | $7.4B | $8.0B | $3.2B | $2.3B | $1.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $9.2B | $9.7B | $10.0B | $10.1B | $9.3B | $8.6B | $9.1B | $9.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.2B | $3.1B | $3.2B | $3.1B | $2.5B | $2.0B | $2.1B | $2.1B |
| Investing Cash Flow | $-1.7B | $-1.0B | $-3.5B | $1.1B | $-5.6B | $-1.1B | $-0.9B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.6B | $-2.1B | $-0.1B | $-4.2B | $3.5B | $-1.1B | $-1.1B | $-1.6B |